There were LOTS of general news important for the psychedelic industry as a whole and very important study results that will influence some of our favorite stocks such as MindMed (MMED / MNMD / MMQ) and Compass Pathways (CMPS)! In today's episode we'll cover a new American psychedelic ETF which is hitting the market under ticker symbol PSY, some new psilocybin and LSD studies, whether MAPS will turn into a public company and some updates on the California and New York bills we have been covering for a while now. Enjoy the episode! Timestamps: 0:00 - Intro 0:40 - The First American Psychedelic ETF (PSY) 5:50 - MAPS Considering An IPO? 12:28 - Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical SSRIs 15:29 - New Study On How LSD Affects The Brain 21:08 - The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD 23:00 - New York Bill Proposes State-Sponsored Psychedelic Research Institute Links: New Psychedelic ETF (NYSE : PSY) : https://www.defianceetfs.com/psy/ https://psychedelicspotlight.com/psy-first-u-s-psychedelic-etf/ Maps Considering An IPO?: https://www.reddit.com/r/shroomstocks/comments/nqoy0z/maps_considering_ipo/ https://youtu.be/v2HycPpjf6Y Study Shows Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical Antidepressants: https://thedalesreport.com/psychedelics/study-shows-psilocybin-assisted-therapy-4-times-more-effective-than-typical-antidepressants/ New Study On How LSD Affects The Brain: https://www.theguardian.com/science/2021/may/19/acid-test-scientists-show-how-lsd-opens-doors-of-perception The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD: https://www.marijuanamoment.net/california-senate-approves-bill-to-legalize-possession-of-psychedelics-like-psilocybin-and-lsd/ New York Bill Proposes State-Sponsored Psychedelic Research Institute: https://psychedelicspotlight.com/new-york-bill-psychedelic-research-institute/ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #PsychedelicStocks #MAPS

GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.

This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere gets its first “smart shop.”